Accelerating Progress in Cancer Research with Streamlined, Patient-Centric, Equitable Clinical Trials: Lessons From Pragmatica-Lung
The onset of COVID-19 posed a grave challenge to researchers as ongoing trials were disrupted by social distancing. But the complicated new circumstances initiated a flurry of innovation that is still evolving the process of research, diagnostics, and approving new therapies.
Ahmed M. Elzawawy, MD, PhD